Development of a Virtual Health Care Platform in Heart Failure Patients Transitioning From Hospital to Home
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07943663. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Feasibility and Performance Evaluation of nucleusRx Virtual Care Platform for Care Management of At-home Heart Failure Patients
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Study will be performed with fifteen (15) Heart Failure (HF) patients for remote monitoring of health and medication adherence following hospital discharges. Participants will be enrolled into two groups: Group 1 (chronic) will be enrolled on Day 30 to 180 post hospital discharge and monitored for 30 days; Group 2 (Acute) will be enrolled on Day 1-3 of hospital discharge after recent HF episodes and monitored for 30 days. Each participant will receive a Pill Dispenser being developed by the study sponsor, a BP machine, a weighing scale and a smartphone loaded with the software developed by the study sponsor that can collect and summarize participant's health data for study physician's/nurse's evaluation. Both BP machine and weighing scale record participant's data automatically to send to the study team physician/nurse for evaluation of his/her health. Outpatient pharmacy will deliver 30 days (+7) of medications as prescribed by the patient's physician in the standard pharmacy vials, and the patients will procure them from their chosen pharmacy outlet. Prescription details for medications will also be sent to the participant's mobile phone. Medications will be uploaded in the dispenser on Day 1 by the patient in presence of a visiting nurse (a member of the study team) who will review and explain medication records with the patient. Nurse will also review and set up the machine as necessary for the daily wellness parameters to be measured and entered by the patient. Data will be collected automatically for the length of the study (30 days). A 24-hr telephone number will be available to each patient to contact study nurse for any issues related to medication dispensing and/or health. Devices will be returned to the study investigator on Day 30 and the remaining pills in the pill dispenser will be manually counted by the study nurse in both groups for comparing against the automatically collected data.
Study identification
- NCT ID
- NCT07943663
- Recruitment status
- Enrolling by invitation
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 15 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 89 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 26, 2025 (Actual)
- Primary completion
- Dec 10, 2026 (Estimated)
- Completion
- Jan 15, 2027 (Estimated)
- Last update posted
- Nov 17, 2026
2025 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UH Portage Medical Center | Ravenna | Ohio | 44266 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07943663, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 17, 2026 · Synced Nov 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.